BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30719695)

  • 21. The Evolving Role of Succinate in Tumor Metabolism: An
    Garrigue P; Bodin-Hullin A; Balasse L; Fernandez S; Essamet W; Dignat-George F; Pacak K; Guillet B; Taïeb D
    J Nucl Med; 2017 Nov; 58(11):1749-1755. PubMed ID: 28619735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
    Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
    Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro.
    Ogawa M; Nakamura S; Saito Y; Kosugi M; Magata Y
    J Nucl Med; 2012 Jan; 53(1):55-8. PubMed ID: 22128324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography.
    Brewer S; McPherson M; Fujiwara D; Turovskaya O; Ziring D; Chen L; Takedatsu H; Targan SR; Wei B; Braun J
    Gastroenterology; 2008 Sep; 135(3):744-55. PubMed ID: 18639553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.
    Cauchon N; Hasséssian HM; Turcotte E; Lecomte R; van Lier JE
    Photochem Photobiol Sci; 2014 Oct; 13(10):1434-43. PubMed ID: 25058054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice.
    Chen Y; Wang L; Liu H; Song F; Xu C; Zhang K; Chen Q; Wu S; Zhu Y; Dong Y; Zhou M; Zhang H; Tian M
    Mol Imaging Biol; 2018 Apr; 20(2):309-317. PubMed ID: 28795272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).
    Molthoff CF; Klabbers BM; Berkhof J; Felten JT; van Gelder M; Windhorst AD; Slotman BJ; Lammertsma AA
    Mol Imaging Biol; 2007; 9(6):340-7. PubMed ID: 17643202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
    Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
    J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
    Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
    J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.
    Takebayashi R; Izuishi K; Yamamoto Y; Kameyama R; Mori H; Masaki T; Suzuki Y
    J Exp Clin Cancer Res; 2013 May; 32(1):34. PubMed ID: 23718763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
    Zhao S; Kuge Y; Kohanawa M; Takahashi T; Zhao Y; Yi M; Kanegae K; Seki K; Tamaki N
    J Nucl Med; 2008 Jan; 49(1):135-41. PubMed ID: 18077525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
    Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Rodrigues RS; Bozza FA; Hanrahan CJ; Wang LM; Wu Q; Hoffman JM; Zimmerman GA; Morton KA
    Nucl Med Biol; 2017 May; 48():52-62. PubMed ID: 28237630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic 2-Deoxy-2-[
    Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
    Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
    Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
    Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
    Cooper AC; Fleming IN; Phyu SM; Smith TA
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring the correction of glycogen storage disease type 1a in a mouse model using [(18)F]FDG and a dedicated animal scanner.
    Zingone A; Seidel J; Aloj L; Caraco C; Vaquero JJ; Jagoda EM; Chou JY; Green MV; Eckelman WC
    Life Sci; 2002 Aug; 71(11):1293-301. PubMed ID: 12106594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.